These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 33361087)
1. IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D. Kiss M; Vande Walle L; Saavedra PHV; Lebegge E; Van Damme H; Murgaski A; Qian J; Ehling M; Pretto S; Bolli E; Keirsse J; Bardet PMR; Arnouk SM; Elkrim Y; Schmoetten M; Brughmans J; Debraekeleer A; Fossoul A; Boon L; Raes G; van Loo G; Lambrechts D; Mazzone M; Beschin A; Wullaert A; Lamkanfi M; Van Ginderachter JA; Laoui D Cancer Immunol Res; 2021 Mar; 9(3):309-323. PubMed ID: 33361087 [TBL] [Abstract][Full Text] [Related]
2. Tumor Cell-Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer. Das S; Shapiro B; Vucic EA; Vogt S; Bar-Sagi D Cancer Res; 2020 Mar; 80(5):1088-1101. PubMed ID: 31915130 [TBL] [Abstract][Full Text] [Related]
3. The Pyroptotic Cell Death Effector Gasdermin D Is Activated by Gout-Associated Uric Acid Crystals but Is Dispensable for Cell Death and IL-1β Release. Rashidi M; Simpson DS; Hempel A; Frank D; Petrie E; Vince A; Feltham R; Murphy J; Chatfield SM; Salvesen GS; Murphy JM; Wicks IP; Vince JE J Immunol; 2019 Aug; 203(3):736-748. PubMed ID: 31209100 [TBL] [Abstract][Full Text] [Related]
4. N-GSDMD trafficking to neutrophil organelles facilitates IL-1β release independently of plasma membrane pores and pyroptosis. Karmakar M; Minns M; Greenberg EN; Diaz-Aponte J; Pestonjamasp K; Johnson JL; Rathkey JK; Abbott DW; Wang K; Shao F; Catz SD; Dubyak GR; Pearlman E Nat Commun; 2020 May; 11(1):2212. PubMed ID: 32371889 [TBL] [Abstract][Full Text] [Related]
5. Inflammasome-mediated GSDMD activation facilitates escape of Candida albicans from macrophages. Ding X; Kambara H; Guo R; Kanneganti A; Acosta-Zaldívar M; Li J; Liu F; Bei T; Qi W; Xie X; Han W; Liu N; Zhang C; Zhang X; Yu H; Zhao L; Ma F; Köhler JR; Luo HR Nat Commun; 2021 Nov; 12(1):6699. PubMed ID: 34795266 [TBL] [Abstract][Full Text] [Related]
6. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. He WT; Wan H; Hu L; Chen P; Wang X; Huang Z; Yang ZH; Zhong CQ; Han J Cell Res; 2015 Dec; 25(12):1285-98. PubMed ID: 26611636 [TBL] [Abstract][Full Text] [Related]
7. Toxoplasma gondii activates a Syk-CARD9-NF-κB signaling axis and gasdermin D-independent release of IL-1β during infection of primary human monocytes. Pandori WJ; Lima TS; Mallya S; Kao TH; Gov L; Lodoen MB PLoS Pathog; 2019 Aug; 15(8):e1007923. PubMed ID: 31449558 [TBL] [Abstract][Full Text] [Related]
8. Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart. Fender AC; Kleeschulte S; Stolte S; Leineweber K; Kamler M; Bode J; Li N; Dobrev D Basic Res Cardiol; 2020 Jan; 115(2):10. PubMed ID: 31912235 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-1β Maturation Triggers Its Relocation to the Plasma Membrane for Gasdermin-D-Dependent and -Independent Secretion. Monteleone M; Stanley AC; Chen KW; Brown DL; Bezbradica JS; von Pein JB; Holley CL; Boucher D; Shakespear MR; Kapetanovic R; Rolfes V; Sweet MJ; Stow JL; Schroder K Cell Rep; 2018 Aug; 24(6):1425-1433. PubMed ID: 30089254 [TBL] [Abstract][Full Text] [Related]
10. Gasdermin D drives focal crystalline thrombotic microangiopathy by accelerating immunothrombosis and necroinflammation. Watanabe-Kusunoki K; Li C; Bandeira Honda TS; Zhao D; Kusunoki Y; Ku J; Long H; Klaus M; Han C; Braun A; Mammadova-Bach E; Linkermann A; Van Avondt K; Richter M; Soehnlein O; Linder MI; Klein C; Steiger S; Anders HJ Blood; 2024 Jul; 144(3):308-322. PubMed ID: 38657197 [TBL] [Abstract][Full Text] [Related]
11. Gasdermin D deficiency attenuates arthritis induced by traumatic injury but not autoantibody-assembled immune complexes. Yang T; Sun K; Wang C; Swarnkar G; Quan S; Kress D; Xiao J; Alippe Y; Zheng H; Brophy RH; Hao D; McAlinden A; Abu-Amer Y; Shen J; Mbalaviele G Arthritis Res Ther; 2021 Nov; 23(1):286. PubMed ID: 34784954 [TBL] [Abstract][Full Text] [Related]
12. Indirect regulation of HMGB1 release by gasdermin D. Volchuk A; Ye A; Chi L; Steinberg BE; Goldenberg NM Nat Commun; 2020 Sep; 11(1):4561. PubMed ID: 32917873 [TBL] [Abstract][Full Text] [Related]
13. Cathepsin G Inhibition by Serpinb1 and Serpinb6 Prevents Programmed Necrosis in Neutrophils and Monocytes and Reduces GSDMD-Driven Inflammation. Burgener SS; Leborgne NGF; Snipas SJ; Salvesen GS; Bird PI; Benarafa C Cell Rep; 2019 Jun; 27(12):3646-3656.e5. PubMed ID: 31216481 [TBL] [Abstract][Full Text] [Related]
14. Gasdermin D Promotes AIM2 Inflammasome Activation and Is Required for Host Protection against Zhu Q; Zheng M; Balakrishnan A; Karki R; Kanneganti TD J Immunol; 2018 Dec; 201(12):3662-3668. PubMed ID: 30404813 [TBL] [Abstract][Full Text] [Related]
15. Macrophages promote growth, migration and epithelial-mesenchymal transition of renal cell carcinoma by regulating GSDMD/IL-1β axis. Xie D; Mao Y; Du N; Ji H; Li J Cytokine; 2022 Nov; 159():156021. PubMed ID: 36057231 [TBL] [Abstract][Full Text] [Related]
16. Burkholderia pseudomallei triggers canonical inflammasome activation in a human primary macrophage-based infection model. Lichtenegger S; Stiehler J; Saiger S; Zauner A; Kleinhappl B; Bernecker C; Schlenke P; Wagner GE; Krause K; Gastager M; Steinmetz I PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008840. PubMed ID: 33137811 [TBL] [Abstract][Full Text] [Related]
17. Gasdermin D Protects from Melioidosis through Pyroptosis and Direct Killing of Bacteria. Wang J; Deobald K; Re F J Immunol; 2019 Jun; 202(12):3468-3473. PubMed ID: 31036765 [TBL] [Abstract][Full Text] [Related]
18. Active Caspase-1 Induces Plasma Membrane Pores That Precede Pyroptotic Lysis and Are Blocked by Lanthanides. Russo HM; Rathkey J; Boyd-Tressler A; Katsnelson MA; Abbott DW; Dubyak GR J Immunol; 2016 Aug; 197(4):1353-67. PubMed ID: 27385778 [TBL] [Abstract][Full Text] [Related]
19. IRF2 transcriptionally induces Kayagaki N; Lee BL; Stowe IB; Kornfeld OS; O'Rourke K; Mirrashidi KM; Haley B; Watanabe C; Roose-Girma M; Modrusan Z; Kummerfeld S; Reja R; Zhang Y; Cho V; Andrews TD; Morris LX; Goodnow CC; Bertram EM; Dixit VM Sci Signal; 2019 May; 12(582):. PubMed ID: 31113851 [TBL] [Abstract][Full Text] [Related]
20. GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model. Boersma B; Puddinu V; Huard A; Fauteux-Daniel S; Wirapati P; Guedri S; Tille JC; McKee T; Pittet M; Palmer G; Bourquin C Front Immunol; 2024; 15():1396777. PubMed ID: 39224600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]